TP53 alterations as a potential diagnostic marker in superficial bladder carcinoma and in patients serum, plasma and

Regine Dahse1, Michael Utting, Wolfram Werner

  • 1Klinikum der FSU Jena, Institut fur Humangenetik, D-07740 Jena, Germany. rdah@mti-n.uni-jena.de

Related Concept Videos